University Hospital Bonn Department of Ophthalmology
Related items
Advanced People list for this Institution with search and filtering
Trial Projects:
- Postoperative Ileus: Duration and Severity Assessment With the SmartPill® (PIDuSA)
- Ranibizumab In Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration Study (RIP)
- Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients (CeTeG)
- Chromoendoskopie versus konventionelle Endoskopie bei Patienten mit Polyposis-Erkrankungen (ChroPol)
- A multicenter, open label, single-arm pilot study to evaluate the efficacy and safety of guselkumab in patients with moderate to severe palmoplantar pustulosis (PPP)
- Echtzeit-Nutzung von automatisierter Intelligenz (CADEYE) bei der Darmkrebs-Überwachung von Patienten mit Lynch-Syndrom
Institutions: University Hospital Bonn Department of Surgery, University Hospital Bonn Department of Ophthalmology, Default Institution
Advanced Trial Projects list for this Institution with search and filtering
The Ranibizumab in Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration (RIP) Study is a prospective, multicenter, uncontrolled, interventional phase 2 clinical trial that investigates the effect of fixed monthly intravitreal injections of ranibizumab (Lucentis, Novartis Pharma, Germany) on visual acuity and retinal morphology over a study period of 12 months in 30 patients.
Public web page: https://clinicaltrials.gov/study/NCT01914159
Start date: 1st Feb 2013
End date: 31st Mar 2016
